Article ID Journal Published Year Pages File Type
3191332 Annals of Allergy, Asthma & Immunology 2014 6 Pages PDF
Abstract
Physicians reported excellent outcomes using primarily newer STP therapies, namely plasma-derived C1 inhibitor, which was discordant to patient-reported outcomes using older STP therapies, namely anabolic steroids. Well-controlled STP studies are needed to clarify use for patients with HAE in the United States.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Authors
, , , , ,